CY2362B1 - Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis. - Google Patents

Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.

Info

Publication number
CY2362B1
CY2362B1 CY0300044A CY0300044A CY2362B1 CY 2362 B1 CY2362 B1 CY 2362B1 CY 0300044 A CY0300044 A CY 0300044A CY 0300044 A CY0300044 A CY 0300044A CY 2362 B1 CY2362 B1 CY 2362B1
Authority
CY
Cyprus
Prior art keywords
pyridone
hydroxy
treatment
seborrheic dermatitis
seborrheic
Prior art date
Application number
CY0300044A
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of CY2362B1 publication Critical patent/CY2362B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
CY0300044A 1996-09-27 2003-05-26 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis. CY2362B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (de) 1996-09-27 1996-09-27 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis

Publications (1)

Publication Number Publication Date
CY2362B1 true CY2362B1 (en) 2004-06-04

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300044A CY2362B1 (en) 1996-09-27 2003-05-26 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.

Country Status (32)

Country Link
EP (1) EP0928183B1 (no)
JP (2) JP2001500884A (no)
KR (1) KR100494207B1 (no)
CN (1) CN1104231C (no)
AR (1) AR008860A1 (no)
AT (1) ATE209891T1 (no)
AU (1) AU716208B2 (no)
BG (1) BG64365B1 (no)
BR (1) BR9711575A (no)
CA (1) CA2267165C (no)
CY (1) CY2362B1 (no)
CZ (1) CZ291485B6 (no)
DE (2) DE19639818A1 (no)
DK (1) DK0928183T3 (no)
ES (1) ES2167721T3 (no)
HK (1) HK1022267A1 (no)
HU (1) HU226955B1 (no)
ID (1) ID21874A (no)
IL (1) IL129141A0 (no)
MA (1) MA24333A1 (no)
MY (1) MY125674A (no)
NO (1) NO312492B1 (no)
NZ (1) NZ334850A (no)
OA (1) OA11028A (no)
PL (1) PL188033B1 (no)
PT (1) PT928183E (no)
RS (1) RS49801B (no)
TR (1) TR199900662T2 (no)
TW (1) TW519491B (no)
UA (1) UA57754C2 (no)
WO (1) WO1998013009A2 (no)
ZA (1) ZA978640B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
EP2197440B1 (en) 2007-08-31 2012-12-26 Janssen Pharmaceutica, N.V. Combinations of imazalil and hydroxypyridones
CN101877968A (zh) 2007-11-30 2010-11-03 詹森药业有限公司 杀真菌的吡咯化合物和pyrion化合物的组合
CA2711762C (en) 2008-02-06 2016-11-01 Jan Pieter Hendrik Bosselaers Combinations of phenylpyrroles and pyrion compounds
JP5870101B2 (ja) 2010-07-01 2016-02-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ ピリオン化合物とポリエチレンイミンとの抗微生物性組み合わせ
ES2573116T3 (es) * 2010-12-02 2016-06-06 The University Of Kansas Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados
WO2013011996A1 (ja) * 2011-07-19 2013-01-24 リジェンティス株式会社 酵母菌から抽出されたポリリン酸，ポリリン酸の塩又はポリリン酸の溶媒和物を含むポリリン酸組成物及びその製造方法。
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) * 2015-03-06 2017-10-10 上药康丽（常州）药业有限公司 一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (de) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Kosmetische Zubereitungen
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
KR950702819A (ko) * 1992-09-08 1995-08-23 제이코버스 코넬리스 레이서 실질적으로 무색의 순한 샴푸 조성물(mild, substantially coloriess shampoo compostion)
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

Also Published As

Publication number Publication date
DE19639818A1 (de) 1998-04-02
AU4774697A (en) 1998-04-17
CZ107599A3 (cs) 1999-06-16
NO991460L (no) 1999-03-25
ID21874A (id) 1999-08-05
HK1022267A1 (en) 2000-08-04
AR008860A1 (es) 2000-02-23
ATE209891T1 (de) 2001-12-15
NO991460D0 (no) 1999-03-25
CA2267165A1 (en) 1998-04-02
AU716208B2 (en) 2000-02-24
WO1998013009A2 (de) 1998-04-02
CA2267165C (en) 2003-12-16
NO312492B1 (no) 2002-05-21
DK0928183T3 (da) 2002-04-02
PT928183E (pt) 2002-05-31
EP0928183B1 (de) 2001-12-05
HUP9903811A1 (hu) 2000-04-28
OA11028A (fr) 2003-03-06
MA24333A1 (fr) 1998-04-01
CN1104231C (zh) 2003-04-02
HUP9903811A3 (en) 2001-11-28
IL129141A0 (en) 2000-02-17
KR20000048613A (ko) 2000-07-25
BR9711575A (pt) 1999-08-24
HU226955B1 (en) 2010-03-29
JP2001500884A (ja) 2001-01-23
EP0928183A2 (de) 1999-07-14
CN1231595A (zh) 1999-10-13
JP2006176540A (ja) 2006-07-06
RS49801B (sr) 2008-06-05
BG103260A (en) 2000-01-31
PL332603A1 (en) 1999-09-27
CZ291485B6 (cs) 2003-03-12
YU13499A (sh) 2001-09-28
DE59705697D1 (de) 2002-01-17
NZ334850A (en) 2001-02-23
TR199900662T2 (xx) 1999-06-21
MY125674A (en) 2006-08-30
PL188033B1 (pl) 2004-11-30
UA57754C2 (uk) 2003-07-15
ES2167721T3 (es) 2002-05-16
TW519491B (en) 2003-02-01
KR100494207B1 (ko) 2005-06-13
WO1998013009A3 (de) 1998-05-14
BG64365B1 (bg) 2004-12-30
ZA978640B (en) 1998-03-27

Similar Documents

Publication Publication Date Title
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
ZA97631B (en) Migraine treatment.
ZA971038B (en) Process for the partial oxidation of alkanes.
ZA991578B (en) Compounds for the treatment of ischemia.
ZA976696B (en) Treated titanium dioxide.
AU2277501A (en) One-step system for cleansing, conditioning, and treating the skin
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
HK1045693A1 (en) Bicyclic compounds composition and method for stabilizing the same.
ZA200006996B (en) Method for the regenaration of sorbent materials.
ZA977859B (en) Annular catheter.
ZA9811507B (en) Combination effective for the treatment of impotence.
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
ZA200003236B (en) Combination therapy for the treatment of migraine.
CY2362B1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
EP0672457A3 (de) Verfahren zur rückstandsfreien Abfallbehandlung.
ZA9710114B (en) Method for the expression of genes.
ZA976350B (en) Treatment of liquid.
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
ZA973843B (en) Treatment of asthma with TNFR-lg.
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
ZA975637B (en) Method for the treatment of emesis.
ZA975306B (en) Flupirtine use.
ZA200003235B (en) Combination therapy for the treatment of migraine.
ZA200002338B (en) Combination therapy for the treatment of migraine.